PDE5A and melanoma: Accordingly, immunohistochemistry analysis in a tissue microarray consisting of triplicate cores of 28 primary and 29 metastatic malignant melanoma cases revealed a statistically significant downregulation of PDE5A in metastatic tumors [267].